Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1% tramadol ophthalmic solution for chronic ocular pain in dry eye
jRCTs011210050Completed
- Sponsor
- Rohto Pharmaceutical Co., Ltd.
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tramadol in dry eye syndrome (DED) and chronic ocular surface pain (COSP), sponsored by Rohto Pharmaceutical Co., Ltd. Started Jan 2022; status: completed.
02
Drugs
tramadol
03
Conditions
dry eye syndrome (DED)chronic ocular surface pain (COSP)
Beyond the preview
Go deeper on jRCTs011210050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011210050.